We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Revolutionary Bio-Hydrogel Implant Coating Could Reduce Risk of Device Rejection

By HospiMedica International staff writers
Posted on 27 Jul 2023

The ongoing fight against infections and microbial resistance continues to pose significant challenges in healthcare. More...

Implant-associated infections, for instance, heighten the risk of device rejection, thereby endangering patient health and adding to the increasing problem of antimicrobial resistance. Conventional treatments, including lengthy antibiotic courses, often fall short against such resilient bacterial communities, further complicating the problem. Now, a new initiative is taking a bold and innovative approach to address this issue by shifting from the conventional method of directly combating pathogenic bacteria to instead harness them as beneficial allies in enhancing tissue regeneration for improved implant integration. This groundbreaking perspective could bring about a paradigm shift in managing infections.

The Bioaction (Europe) project, a collaboration involving four research centers, two universities, and two companies from five European countries, is set to develop functional bio-hydrogels. These hydrogels are designed to trigger local remodeling of physiological processes to expedite healing and stimulate bone growth. They will be designed as injectable materials or implant coatings for minimally invasive applications. Over the next four years, the project's researchers will validate this technology using clinically relevant models for dental implants and permanent transcutaneous prostheses. However, the transformative influence of Bioaction reaches beyond these specific applications. By reducing dependence on extended antibiotic treatments and minimizing failure rates, this trailblazing project has the potential to revolutionize methods of treating infections. Ultimately, Bioaction aims to enhance patient quality of life while making a significant contribution to the global fight against antimicrobial resistance.

“The Bioaction project proposes a visionary approach that will be pursued thanks to real interdisciplinarity,” said Luigi Ambrosio, project coordinator. “Our partners’ diverse expertise and skills in synthetic biology, biomaterials, microbiology, and beyond will surely be the basis for the project’s success.”

Related Links:
Bioaction


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.